Prof Igor Goryanin and his team are working with the Riken Genomic Research Centre in Japan to investigate the effectiveness of breast cancer treatments.
Prof Goryanin is the Henrik Kacser Chair in Computational Systems Biology, Director of the Computational Systems Biology Group and the Edinburgh Centre for Bioinformatics, and Co-Director of the Centre for Systems Biology.
His team are currently involved in several high profile international collaborations with research groups across Europe, China, Japan and the USA.
Recently the team commenced a major five-year project with the internationally respected Riken Genomic Research Centre in Japan.
The project will look at why particular treatments for breast cancer work in some patients and not in others.
It will use advanced computer systems set up at Edinburgh’s School of Informatics to run programmes incorporating expertise from cellular biologists in Japan.
The overall project aim is to better understand the make-up of particular drugs and why their effectiveness differs among patients.
It is hoped that the database will be able to narrow down the different types of drugs that should be prescribed to individual patients and what types of combination therapy would have the best outcome.
We hope to further our research and look at other cancers as well as diseases such as heart disease and neural and psychiatric diseases. Identifying which drugs have the best responses in particular patients would not only save lives but would also save the UK NHS money as treatment with expensive drugs can be tailor-made for whom it works.
Prof Igor Goryanin
This article was published on Jun 22, 2010